HSP90 inhibitors have previously been shown to be effective in SHH-dependent medulloblastoma models62 and require a wild-type, functional p53 in mediating their efficacy in inducing apoptosis of tumor cells. This evidence concerns the gene HSP90AB1 and neoplasm.